section name header

Pathophys and Cause

Jama 2004;291:2994; Nejm 2000;342:1802; male and female—Jama 1999;281:537

Cause:Drugs including thiazides, -blockers, clonidine, alpha-methyldopa (Aldomet), cimetidine, SSRI and other psychiatric medications, chemotherapy of cancer, and a long list of others that occasionally cause it (Med Let 1987;29:65); diabetes (Nejm 1989;320:1025); prolactin tumors, male menopause, hypogonadism (high FSH and LH, low testosterone); endothelial dysfunction, prostatectomy, prostate irradiation

Epidemiology

Prevalence = 39% at age 40 yr, 67% at age 70 yr (J Urol 1994;151:54); vs 7% at age 25 yr, 11% at age 45 yr, 18% at 55 yr (Jama 1999;281:537). In healthy thin men, <5% at age 50 yr, 10% at 60 yr, 20% at 70 yr, 60% at 80 yr (Ann IM 2003;139:161)

Signs and Symptoms

Si:Rectal exam for prostate nodules, neurologic and vascular exams

Complications

r/o ejaculatory dysfunction, decreased libido

Lab and Xray

Lab: Chem:Testosterone total and free, prolactin, LH, FSH, FBS, PSA

Treatment

Rx:

(Jama 1997;277:7)

Testosterone 200 mg

Bupropion 150 mg po qd-bid helps 30% including women; often used w antidepressants that decr sexual function

Vasoactive drugs:

Vacuum/constriction devices: vacuum devices (Erecaid), or adjustable bands (Actis or Rejoyn) work but are clumsier

Prostheses, permanent or inflatable, surgically implanted

Pathophys and Cause

Epidemiology

Signs and Symptoms

Complications

Lab and Xray

Treatment